Simon Senanu: A Stepwise Laboratory Approach for aPTT Prolongation
Simon Senanu, Medical Laboratory Scientist at Perkins Medical Centre, shared a post on LinkedIn:
“aPTT Prolongation – A Stepwise Laboratory Approach
A prolonged activated partial thromboplastin time (aPTT) is a common laboratory finding.
But not all prolongations indicate a bleeding disorder.
The key lies in a structured interpretation.
What Does aPTT Assess?
aPTT evaluates the intrinsic and common pathways:
- Factor XII, XI, IX, VIII
- Factor X, V, II (prothrombin), fibrinogen
Any defect, inhibitor, or interference in these pathways can prolong aPTT.
Step 1: Confirm the Result
Before interpretation, rule out pre-analytical errors:
- Underfilled citrate tube (incorrect blood-to-anticoagulant ratio)
- Clotted sample
- Heparin contamination (e.g., line draws)
Always repeat if the result is unexpected.
Step 2: Perform a Mixing Study
Mix patient plasma with normal plasma (1:1):
- Correction of aPTT – Suggests factor deficiency
- No correction – Suggests circulating inhibitor
This is the most critical step in narrowing the cause.
If It Corrects – Think Factor Deficiency
Common etiologies:
- Hemophilia A (Factor VIII deficiency)
- Hemophilia B (Factor IX deficiency)
- Factor XI deficiency
- Severe von Willebrand disease (via reduced Factor VIII)
Factor XII deficiency can prolong aPTT but does not cause bleeding – a key diagnostic trap.
If It Does Not Correct – Think Inhibitor or Anticoagulant
Key causes:
- Lupus anticoagulant (LA)
- Specific factor inhibitors (e.g., acquired Factor VIII inhibitor)
- Heparin or direct anticoagulants
Lupus anticoagulant prolongs phospholipid – dependent assays but is associated with thrombosis.
Pattern Recognition in Practice
- Isolated prolonged aPTT plus bleeding – Hemophilia or severe vWD
- Isolated prolonged aPTT plus thrombosis – Lupus anticoagulant
- Prolonged aPTT plus normal PT plus no symptoms – Likely benign cause or artifact
- Prolonged aPTT plus clinical deterioration – Consider acquired inhibitor
Laboratory Pitfalls
- Heparin contamination mimicking inhibitor patterns
- Acute phase reactions altering factor levels
- Delayed testing affecting labile factors (especially Factor VIII)
Always integrate clinical plus laboratory data.
Clinical Significance
A prolonged aPTT can indicate:
- Inherited bleeding disorders
- Acquired inhibitors
- Antiphospholipid syndrome
- Anticoagulant therapy effects
Misinterpretation can lead to inappropriate management.
Laboratory Takeaway
aPTT prolongation is not a diagnosis – it is a starting point.
Think systematically:
Error – Mixing study – Deficiency vs inhibitor – Clinical correlation
When you see a prolonged aPTT, what’s your immediate instinct – repeat the test or proceed directly to a mixing study?”

Other posts featuring Simon Senanu on Hemostasis Today.
-
Nov 19, 2026, 16:27263 PolyU Students and Staff Unite to Donate Blood – Hong Kong Red Cross Blood Transfusion Service
-
Nov 19, 2026, 16:16Billy Otieno: The Future of Blood Donation Lies Beyond Collection
-
Nov 19, 2026, 15:58Hema Goyal: Hematocon 2026 Bringing Together Knowledge, Innovation and Excellence in Hematology
-
Nov 19, 2026, 15:44Chukwuemeka Amarachi: Understanding Complex Blood Grouping Beyond Routine ABO And RhD Typing
-
Nov 19, 2026, 14:19Long-Read Sequencing Is Closing Diagnostic Gaps in Inherited Bleeding Disorders
-
Nov 19, 2026, 13:36Raja Prince: Protein S Silencing and the Future of Hemostatic Therapy
-
Nov 19, 2026, 13:26M. Sekip Altunkan: The Thrombotic Risk of Andexanet Alfa
-
Nov 19, 2026, 13:18Felice Gragnano: Personalizing Antiplatelet Therapy After PCI
-
Nov 19, 2026, 13:11When Postpartum Warning Signs Are Ignored – National Blood Clot Alliance